ADELPHI, Maryland (Reuters) - Health advisers recommended a revision of labels for the widely used new Generation of Birth Control pills, based on data showing they may put women at a higher risk of dangerous blood clots. Outside experts advising the Food and Drug Administration on Thursday voted 21-5 that current labels inadequate reflected the risks and benefits of a newer generation of pills that contain the compound drospirenone, including Bayer AG's popular Yaz and Yasmin. ...read more..
source:http://yhoo.it/uQev5J
No comments:
Post a Comment